The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $164.70

Today's change+1.56 +0.96%
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $164.70

Today's change+1.56 +0.96%
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.

Amgen Inc up (U.S.)$1.56

Amgen Inc closed up Tuesday by (U.S.)$1.56 or 0.96% to (U.S.)$164.70. Over the last five days, shares have gained 2.14% and 12.65% year to date. Shares have underperformed the S&P 500 by 13.65% during the last year.

Key company metrics

  • Open(U.S.) $163.52
  • Previous close(U.S.) $163.14
  • High(U.S.) $165.30
  • Low(U.S.) $163.40
  • Bid / Ask(U.S.) $164.90 / (U.S.) $167.00
  • YTD % change+12.65%
  • Volume3,529,408
  • Average volume (10-day)2,528,992
  • Average volume (1-month)4,036,803
  • Average volume (3-month)3,661,887
  • 52-week range(U.S.) $133.64 to (U.S.) $184.21
  • Beta1.28
  • Trailing P/E16.05×
  • P/E 1 year forward13.21×
  • Forward PEG2.19×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.79%
  • Trailing EPS(U.S.) $10.26
Updated April 25 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,9655,8115,6885,527
Total other revenue--------
Total revenue5,9655,8115,6885,527
Gross profit4,8984,7844,6384,509
Total cost of revenue1,0671,0271,0501,018
Total operating expense3,4803,2843,3083,125
Selling / general / administrative1,3231,2441,2921,203
Research & development1,078990900872
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-607827
Other operating expenses, total1823-125
Operating income2,4852,5272,3802,402
Interest income (expense), net non-operating-328-325-313-294
Gain (loss) on sale of assets--------
Other--------
Income before tax2,2832,4182,2042,258
Income after tax1,9352,0171,8701,900
Income tax, total348401334358
Net income1,9352,0171,8701,900
Total adjustments to net income--------
Net income before extra. items1,9352,0171,8701,900
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9352,0171,8701,900
Inc. avail. to common incl. extra. items1,9352,0171,8701,900
Diluted net income1,9352,0171,8701,900
Dilution adjustment--------
Diluted weighted average shares742753756760
Diluted EPS excluding extraordinary itemsvalue per share2.612.682.472.50
Dividends per sharevalue per share1.001.001.001.00
Diluted normalized EPSvalue per share2.602.682.562.53